Literature DB >> 2998697

Diagnosis and prophylaxis of infectious bovine rhinotracheitis: the role of virus latency.

P P Pastoret, E Thiry.   

Abstract

Efficient methods of diagnosis and prophylaxis of infectious bovine rhinotracheitis must consider the concept of latency of the etiological agent, infectious bovine rhinotracheitis virus (Bovine herpesvirus 1; BHV 1). The identification of BHV 1 in nasal mucus samples or a rise in specific antibodies have to be cautiously interpreted, because they can signify either a primary infection or a reexcretion of the virus after reactivation. The isolated virus can also either be a vaccine or a virulent strain. Another aspect of BHV 1 infection diagnosis is the detection of latent carriers, which are able to transmit the virus to uninfected animals; delayed hypersensitivity test seems to be a good candidate. The classical methods of prophylaxis protect the animal against the disease, but they should also impede the reexcretion of virulent strains by latent carriers. Since, in several countries, attenuated viruses are used as vaccines, a special emphasis has to be laid on the persistence of these vaccine viruses in a latent form in the bovine population.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998697     DOI: 10.1016/0147-9571(85)90052-9

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  8 in total

1.  Latency and reactivation of infectious laryngotracheitis vaccine virus.

Authors:  C S Hughes; R A Williams; R M Gaskell; F T Jordan; J M Bradbury; M Bennett; R C Jones
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

Review 2.  BHV-1: new molecular approaches to control a common and widespread infection.

Authors:  L Turin; S Russo; G Poli
Journal:  Mol Med       Date:  1999-05       Impact factor: 6.354

3.  Production of bovine herpesvirus type 1-seronegative latent carriers by administration of a live-attenuated vaccine in passively immunized calves.

Authors:  M Lemaire; G Meyer; E Baranowski; F Schynts; G Wellemans; P Kerkhofs; E Thiry
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

4.  An inactivated vaccine from a field strain of bovine herpesvirus-1 (BoHV-1) has high antigenic mass and induces strong efficacy in a rabbit model.

Authors:  Julian Ruiz-Sáenz; Jairo Jaime; Victor Vera
Journal:  Virol Sin       Date:  2013-02-06       Impact factor: 4.327

5.  Pathogens of bovine respiratory disease in North American feedlots conferring multidrug resistance via integrative conjugative elements.

Authors:  Cassidy L Klima; Rahat Zaheer; Shaun R Cook; Calvin W Booker; Steve Hendrick; Trevor W Alexander; Tim A McAllister
Journal:  J Clin Microbiol       Date:  2013-11-20       Impact factor: 5.948

6.  Reintroduction of bovine herpes virus type 1 into Danish cattle herds during the period 1991-1995: a review of the investigations in the infected herds.

Authors:  B Nylin; K G Madsen; L Rønsholt
Journal:  Acta Vet Scand       Date:  1998       Impact factor: 1.695

7.  Long-term study (2005-2010) on the vaccination with BoHV-1 glycoprotein E-deleted marker vaccine in selected two dairy herds in Turkey.

Authors:  Feray Alkan; S Bilge-Dagalp; Z Karapınar; M O Timurkan; N Coskun; I Burgu
Journal:  Trop Anim Health Prod       Date:  2017-10-25       Impact factor: 1.559

Review 8.  Antibody Responses to Bovine Alphaherpesvirus 1 (BoHV-1) in Passively Immunized Calves.

Authors:  Stefano Petrini; Carmen Iscaro; Cecilia Righi
Journal:  Viruses       Date:  2019-01-02       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.